Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06952517
PHASE2

Efficacy and Safety of Topical Clascoterone (WINLEVI) Cream 1% in Patients With Facial Acneiform Rosacea

Sponsor: Narrows Institute for Biomedical Research

View on ClinicalTrials.gov

Summary

To demonstrate the efficacy of Clascoterone cream 1% in reducing the size of sebaceous glands in study participants with acneiform rosacea.

Official title: Efficacy and Safety of Topical Clascoterone Cream 1% in Patients With Facial Acneiform Rosacea

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

20

Start Date

2025-03-14

Completion Date

2025-09-30

Last Updated

2025-05-06

Healthy Volunteers

Yes

Interventions

DRUG

Clascoterone Cream 1%

Clascoterone 1% cream

Locations (1)

New York Harbor VA Brooklyn Campus

Brooklyn, New York, United States